{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T08:08:53Z","timestamp":1784448533516,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinthera.2025.11.012","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:33:57Z","timestamp":1765802037000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ciprofol Injection Combined With 6 Cephalosporins During Simulated Y-site Mixing: A Physicochemical Compatibility Study for Perioperative Administration"],"prefix":"10.1016","volume":"48","author":[{"given":"Baoxia","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinguo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9738-6744","authenticated-orcid":false,"given":"Fuchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0001","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/ajhp\/zxac262","article-title":"Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration","volume":"80","author":"Kondo","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111425","article-title":"Efficacy and safety of ciprofol compared with propofol during general anesthesia induction: a systematic review and meta-analysis of randomized controlled trials (RCT)","volume":"94","author":"Akhtar","year":"2024","journal-title":"J Clin Anesth"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0003","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12876-025-03734-0","article-title":"Safety and efficacy of ciprofol versus propofol for gastrointestinal endoscopy: a meta-analysis","volume":"25","author":"Cheng","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0004","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2147\/DDDT.S475176","article-title":"Efficacy and safety of general anesthesia induction with ciprofol in hip fracture surgery of elderly patients: a randomized controlled trial","volume":"18","author":"Lu","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2147\/DDDT.S497554","article-title":"Effects of ciprofol and propofol general anesthesia on postoperative recovery quality in patients undergoing ureteroscopy: a randomized, controlled, double-blind clinical trial","volume":"19","author":"Shi","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0006","series-title":"Global guidelines for the prevention of surgical site infection","year":"2018"},{"issue":"11","key":"10.1016\/j.clinthera.2025.11.012_bib0007","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/antibiotics11111543","article-title":"Meta-analysis of clinical trials comparing cefazolin to cefuroxime, ceftriaxone, and cefamandole for surgical site infection prevention","volume":"11","author":"Ahmed","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0008","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12871-024-02613-7","article-title":"Incompatibility of the short- acting benzodiazepine remimazolam with common perioperative medication","volume":"24","author":"Hofmann","year":"2024","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12871-020-01194-5","article-title":"The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion","volume":"20","author":"Henkel","year":"2020","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"10.1016\/j.clinthera.2025.11.012_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkg134","article-title":"Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units","volume":"51","author":"Baririan","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0011","first-page":"52","article-title":"Physical compatibility of cefiderocol with selected intravenous drugs during simulated Y-site administration","volume":"25","author":"Lu","year":"2021","journal-title":"Int J Pharm Compd"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0012","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/ajhp\/zxac262","article-title":"Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration","volume":"80","author":"Kondo","year":"2023","journal-title":"Am J Health Syst Pharm"},{"issue":"13","key":"10.1016\/j.clinthera.2025.11.012_bib0013","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1093\/ajhp\/zxae035","article-title":"Physical compatibility of colistin with analgesics during simulated Y-site administration","volume":"81","author":"Dettlaff","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0014","series-title":"Pharmacopoeia of the People\u2019s Republic of China: general rule 9101","first-page":"480","year":"2020"},{"issue":"11\u201312","key":"10.1016\/j.clinthera.2025.11.012_bib0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1159\/000519236","article-title":"Physical and chemical compatibility of etomidate and propofol injectable emulsions","volume":"106","author":"Wang","year":"2021","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.clinthera.2025.11.012_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/ejhpharm-2023-004027","article-title":"Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study","volume":"32","author":"Roche","year":"2025","journal-title":"Eur J Hosp Pharm"},{"issue":"e1","key":"10.1016\/j.clinthera.2025.11.012_bib0017","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1136\/ejhpharm-2019-002076","article-title":"Evaluation of the stability of vancomycin solutions at concentrations used in clinical services","volume":"27","author":"Masse","year":"2020","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"10.1016\/j.clinthera.2025.11.012_bib0018","first-page":"24","article-title":"Study on the compatibility of cefotaxime sodium with Ornidazole sodium chloride injection","volume":"10","author":"Li","year":"2013","journal-title":"Chinese Pharmacovigilance"},{"issue":"3","key":"10.1016\/j.clinthera.2025.11.012_bib0019","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1345\/aph.1R777","article-title":"Incompatibility of piritramide with cephalosporins","volume":"47","author":"Eckle","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"22","key":"10.1016\/j.clinthera.2025.11.012_bib0020","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ajhp\/52.22.2567","article-title":"Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection","volume":"52","author":"Mantong","year":"1995","journal-title":"Am J Health Syst Pharm"},{"issue":"15","key":"10.1016\/j.clinthera.2025.11.012_bib0021","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/ajhp\/54.15.1735","article-title":"Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0022","first-page":"16","article-title":"Evaluation visual of the physical compatibility of naloxone with other usual intravenous drugs","volume":"46","author":"Tollec","year":"2013","journal-title":"Pharmactuel"},{"issue":"5","key":"10.1016\/j.clinthera.2025.11.012_bib0023","first-page":"995","article-title":"Visual compatibility of hetastarch with injectable critical-care drugs","volume":"46","author":"Wohlford","year":"1989","journal-title":"Am J Hosp Pharm"},{"issue":"21","key":"10.1016\/j.clinthera.2025.11.012_bib0024","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/ajhp\/53.21.2639","article-title":"Incompatibility between ceftriaxone sodium and labetalol hydrochloride","volume":"53","author":"Leader","year":"1996","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.clinthera.2025.11.012_bib0025","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acs.energyfuels.9b03565","article-title":"\u03b6 Potential as a measure of asphalt emulsion stability","volume":"34","author":"Pinto","year":"2020","journal-title":"Energy Fuel"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0026","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 What they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.clinthera.2025.11.012_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38428-8","article-title":"Stability of the emulsion during the injection of anionic and cationic surfactants in the presence of various salts","volume":"13","author":"Garmsiri","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clinthera.2025.11.012_bib0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ics.12108","article-title":"Physical and material properties of an emulsion-based lipstick produced via a continuous process","volume":"36","author":"Beri","year":"2014","journal-title":"Int J Cosmet Sci"},{"issue":"1\u20132","key":"10.1016\/j.clinthera.2025.11.012_bib0029","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijpharm.2017.06.040","article-title":"The role of lecithin degradation on the pH dependent stability of halofantrine encapsulated fat nano- emulsions","volume":"528","author":"Haidar","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clinthera.2025.11.012_bib0030","article-title":"Influence of extraction pH and homogenization on soybean oleosome emulsion stability","author":"Qi","year":"2024","journal-title":"LWT"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825004096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825004096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:22:57Z","timestamp":1769610177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825004096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0149291825004096"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciprofol Injection Combined With 6 Cephalosporins During Simulated Y-site Mixing: A Physicochemical Compatibility Study for Perioperative Administration","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}